Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020 Download PDF
25/02/2020 Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP® for Complicated Urinary Tract Infections Download PDF
03/09/2019
Allecra Therapeutics to Present Data at ASM/ESCMID 2019 Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
Download PDF
22/08/2018
Allecra Therapeutics successfully enters next development phase
Download PDF
17/04/2018
Allecra Therapeutics to present data at 28th European Congress of Clinical Microbiology and Infectious Diseases
Download PDF
26/03/2018
Allecra Therapeutics announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, Enmetazobactam, in Combination with Cefepime to treat complicated Urinary Tract Infections (cUTI)
03/04/2018
Allecra Therapeutics announces participation at
the H.C. Wainwright annual global life sciences conference in
Monte Carlo, Monaco on April 8-10,2018 Download PDF
04/05/2017
Allecra Therapeutics Strengthens Leadership
Team with Appointment of New Chairman and Chief Medical
Officer
Download PDF
4/12/2017
Allecra Therapeutics Announces New Staged
Financing Deal to Take the Company Through to End of
Phase 3
Download PDF
